Logo image of VATE

INNOVATE CORP (VATE) Stock Fundamental Analysis

NYSE:VATE - New York Stock Exchange, Inc. - US45784J3032 - Common Stock - Currency: USD

5.37  -0.08 (-1.47%)

Fundamental Rating

2

VATE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 49 industry peers in the Construction & Engineering industry. Both the profitability and financial health of VATE have multiple concerns. VATE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

VATE had negative earnings in the past year.
In the past year VATE had a positive cash flow from operations.
VATE had negative earnings in each of the past 5 years.
VATE had a positive operating cash flow in 4 of the past 5 years.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

The Return On Assets of VATE (-4.94%) is worse than 75.51% of its industry peers.
The Return On Invested Capital of VATE (175.43%) is better than 100.00% of its industry peers.
VATE had an Average Return On Invested Capital over the past 3 years of 4.95%. This is significantly below the industry average of 16.67%.
The 3 year average ROIC (4.95%) for VATE is below the current ROIC(175.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.94%
ROE N/A
ROIC 175.43%
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

VATE has a Operating Margin (4.25%) which is in line with its industry peers.
In the last couple of years the Operating Margin of VATE has declined.
The Gross Margin of VATE (19.29%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of VATE has declined.
Industry RankSector Rank
OM 4.25%
PM (TTM) N/A
GM 19.29%
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

VATE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
VATE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VATE has less shares outstanding
The debt/assets ratio for VATE is higher compared to a year ago.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

VATE has an Altman-Z score of -0.10. This is a bad value and indicates that VATE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VATE (-0.10) is worse than 85.71% of its industry peers.
The Debt to FCF ratio of VATE is 288.44, which is on the high side as it means it would take VATE, 288.44 years of fcf income to pay off all of its debts.
VATE has a worse Debt to FCF ratio (288.44) than 61.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 288.44
Altman-Z -0.1
ROIC/WACC26.62
WACC6.59%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

VATE has a Current Ratio of 0.44. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
VATE has a worse Current ratio (0.44) than 89.80% of its industry peers.
VATE has a Quick Ratio of 0.44. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of VATE (0.42) is worse than 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.42
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

1

3. Growth

3.1 Past

VATE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -103.29%.
The Revenue for VATE has decreased by -24.94% in the past year. This is quite bad
The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-103.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-759.09%
Revenue 1Y (TTM)-24.94%
Revenue growth 3Y-2.79%
Revenue growth 5Y0.55%
Sales Q2Q%-13.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2023 0 10 -10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VATE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

91.84% of the companies in the same industry are more expensive than VATE, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as VATE.
Industry RankSector Rank
P/FCF 31.01
EV/EBITDA 9.04
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VATE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATE CORP

NYSE:VATE (7/21/2025, 2:50:37 PM)

5.37

-0.08 (-1.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05
Inst Owners19.94%
Inst Owner Change-0.72%
Ins Owners52.7%
Ins Owner Change4.02%
Market Cap71.31M
Analysts82.86
Price TargetN/A
Short Float %7.21%
Short Ratio12.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)0.76%
DP-2.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF 31.01
P/OCF 3.5
P/B N/A
P/tB N/A
EV/EBITDA 9.04
EPS(TTM)-3.39
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY3.23%
OCF(TTM)1.54
OCFY28.61%
SpS80.28
BVpS-14.16
TBVpS-36.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.94%
ROE N/A
ROCE 222.06%
ROIC 175.43%
ROICexc N/A
ROICexgc N/A
OM 4.25%
PM (TTM) N/A
GM 19.29%
FCFM 0.22%
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
ROICexc(3y)5.63%
ROICexc(5y)N/A
ROICexgc(3y)24.72%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
F-Score4
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 288.44
Debt/EBITDA 1.8
Cap/Depr 55.86%
Cap/Sales 1.7%
Interest Coverage 0.93
Cash Conversion 26.25%
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.42
Altman-Z -0.1
F-Score4
WACC6.59%
ROIC/WACC26.62
Cap/Depr(3y)52.64%
Cap/Depr(5y)57.69%
Cap/Sales(3y)1.42%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-103.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-759.09%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.94%
Revenue growth 3Y-2.79%
Revenue growth 5Y0.55%
Sales Q2Q%-13.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.83%
EBIT growth 3YN/A
EBIT growth 5Y-8.4%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y105.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y188.31%
OCF growth 3Y-65.54%
OCF growth 5Y-39.31%